0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°íÇü¾Ï ¿Ü·¡ ȯÀÚÀÇ Á¤¸ÆÆ÷Æ® ÇìÆĸ° °ü·ù Áֱ⠿¬Àå¿¡ °üÇÑ ÀüÇâÀû Á¶»ç

A Prospective Study of Extending the Implanted Port Heparin Flushing Cycle in Outpatients with Solid Tumors

¼ºÀΰ£È£ÇÐȸÁö 2018³â 30±Ç 2È£ p.216 ~ 225
KMID : 0367020180300020216
±èÇý°æ ( Kim Hye-Kyung ) - °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø ¾Ï¼¾ÅÍ

±¸Çö°æ ( Ku Hyun-Kyung ) - °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø ¾Ï¼¾ÅÍ
ÃÖ¼ÒÀº ( Choi So-Eun ) - ±¹¸³¸ñÆ÷´ëÇб³ °£È£Çаú

Abstract

Purpose: This prospective study was done to determine if it is possible to extend the implanted port heparin flushing cycle.

Methods: Patients enrolled in the study had their port flushed once 8 weeks or more in a tertiary hospital between July 2015 and November 2016. They were observed until they had completed six scheduled flushes or developed any port-related complication. Functional outcomes at heparin flushing were evaluated by using port infection, normal saline injection, blood aspiration and patient's posture during heparin administration.

Results: A total of 24 patients were enrolled and total of 72 cases of heparin flush were observed. The median heparin flushing interval was 95 days. No infection of port or problem with saline injection occurred. But there were 6 cases of initial difficult and 1 case of difficult in blood aspiration. However, there was not any case to get rid of the heparin flush, nor were there any patients noted who were not able to use it.

Conclusion: It was confirmed that there was no problem in the status and function of the implanted port, even if the heparin flush cycle was extended to 8 weeks or more.
KeyWords
Á¤¸ÆÆ÷Æ®, °íÇü¾Ï, ÇìÆĸ°, °ü·ù
Vascular access devices, Neoplasms, Heparin, Flushing
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed